Modeled smoking-effect onset geometry for sildenafil is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, and dose-scaling geometry shape the rising-phase trajectory under parameter sets representing smoking-linked conditions. “Onset” refers strictly to modeled PK→PD behavior, not real-world timing. Absorption rate determines rising-phase steepness, absorption timing determines temporal alignment, solubility determines dissolution-driven availability, and modeled gastric emptying determines input arrival. Distribution loading determines early central availability, while distribution geometry determines compartmental spread and redistribution timing. Clearance geometry determines removal dynamics, with first-pass metabolism and bioavailability shaping the modeled systemic input. Dose-scaling geometry determines how the parameterized input is represented relative to reference trajectories. PD interpretation then defines modeled onset geometry: threshold placement establishes the onset boundary, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add interpretation variability. Link to onset time.
Modeled smoking-effect “effectiveness geometry” for sildenafil describes how PD functions transform modeled PK concentration differences into a geometric interpretation space; it does not represent real-world effectiveness. Faster modeled absorption steepens the rising phase, earlier absorption timing shifts the trajectory coordinate, and solubility determines dissolution-driven availability. A parameterized gastric-emptying term can shift input arrival, while absorption-window width controls how broadly input is distributed across the rising phase. Distribution loading determines early central-compartment concentration, distribution geometry determines how absorbed material spreads between modeled compartments, and redistribution timing shapes subsequent trajectory transitions. Clearance geometry controls removal curvature, while first-pass metabolism and bioavailability determine the modeled systemic exposure input. Dose-scaling geometry determines how smoking-linked parameter sets are compared with reference dose trajectories. Concentration-dependent clearance can further alter curvature as concentration changes. Under effectiveness modeling, the PK trajectory supplies the input function that PD parameters transform into modeled effectiveness coordinates. Link to pk speed.
PD geometry determines how modeled smoking-effect onset and effectiveness differences are represented after PK trajectories have been generated. Threshold placement determines where the concentration trajectory intersects the modeled PD coordinate, establishing the mathematical onset boundary. Binding sensitivity determines how concentration differences are transformed into binding differences; higher modeled sensitivity can expand separation, while lower sensitivity can compress it. Coupling geometry determines how binding is mapped into downstream PD signals, with shallow slopes broadening modeled transitions and steep slopes compressing them. PD noise bands widen or narrow interpretation regions around calculated coordinates. Smoking-linked sildenafil simulations can use differing parameter sets for absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, redistribution timing, clearance geometry, first-pass metabolism, bioavailability, Tmax geometry, and Cmax geometry. The resulting PK differences may then be expanded, compressed, or shifted by PD mapping. Link to lifestyle speed.
The PK layer represents smoking-effect geometry through parameterized changes in the concentration trajectory rather than through clinical interpretation. Absorption rate controls the mathematical steepness of the rising phase, while absorption timing determines where that phase is positioned along the modeled time coordinate. Solubility influences dissolution-driven input, and gastric emptying determines the modeled arrival pattern of material into the absorption process. Absorption-window width controls whether input is concentrated into a narrow interval or distributed across a broader interval. Distribution loading determines initial central-compartment placement, distribution geometry controls movement between modeled compartments, and redistribution timing shapes later concentration transitions. Clearance geometry controls the descending trajectory, while first-pass metabolism and bioavailability modify the modeled systemic input. Dose-scaling geometry determines how the smoking-linked parameter set is scaled against a reference trajectory. Tmax geometry identifies the modeled peak coordinate, and Cmax geometry describes modeled peak amplitude. Link to absorption rate.
PK variability produces families of modeled smoking-effect trajectories rather than a single deterministic curve. Changes in absorption rate alter rising-phase slope, while absorption timing and gastric emptying shift the location of the input function. Solubility and absorption-window width modify how concentrated or dispersed the modeled input becomes. Distribution loading changes the initial concentration coordinate, distribution geometry changes compartmental allocation, and redistribution timing modifies later trajectory curvature. Clearance geometry, concentration-dependent clearance, first-pass metabolism, and bioavailability alter the shape and scale of systemic exposure. Dose-scaling geometry provides the mathematical framework for comparing differently parameterized inputs. Tmax geometry can therefore vary in modeled location, while Cmax geometry can vary in modeled amplitude. These PK differences generate different calculated regions for subsequent PD transformation. When parameter ranges are represented together, the resulting envelope describes modeled onset and effectiveness geometry across the specified smoking-effect parameter space rather than an observed clinical distribution. Link to distribution speed.
| PK Domain | Smoking-Effect Interaction | Link |
|---|---|---|
| Absorption Rate | Steeper or flatter rising phase. | absorption rate |
| Gastric Emptying | Shifted modeled input arrival. | food effect speed |
| Distribution Geometry | Modeled compartmental spread. | distribution speed |
Threshold placement determines the modeled coordinate at which a smoking-linked PK trajectory crosses the defined PD boundary. In this framework, onset is therefore a mathematical intersection between a concentration trajectory and a selected threshold, rather than a real-world timing statement. If threshold placement is shifted upward, the modeled crossing occurs at a different trajectory coordinate; if shifted downward, the coordinate changes in the opposite direction. Binding sensitivity then determines how strongly concentration differences are converted into modeled binding differences around that threshold. Coupling geometry controls the subsequent transformation from binding into a downstream PD signal. The resulting onset coordinate can therefore change even when the underlying PK trajectory remains unchanged, because the PD mapping function has changed. PD noise bands add a bounded interpretation region around calculated coordinates, representing modeled uncertainty or variability in the transformation. These elements collectively define how smoking-effect PK trajectories are translated into modeled onset and effectiveness geometry. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands determine how strongly PK differences are expressed in modeled smoking-effect interpretation space. Binding sensitivity controls the local response of the PD transformation to concentration changes; greater modeled sensitivity can increase geometric separation between nearby PK trajectories, whereas lower sensitivity can compress that separation. Coupling geometry determines the slope and curvature of the downstream transformation, so different coupling functions can produce different modeled effectiveness coordinates from the same PK input. PD noise bands surround those calculated coordinates with an interpretation range, preventing a single mathematical trajectory from being treated as an exact point. The PK layer still supplies the underlying differences through absorption rate, absorption timing, distribution geometry, clearance geometry, Tmax, and Cmax. Consequently, a modest PK displacement may become more pronounced, less pronounced, or differently shaped after PD transformation. The framework describes mathematical mapping behavior only, without assigning real-world effectiveness or interaction outcomes. Link to pk speed.
| PD Domain | Smoking-Effect PD Interaction | Link |
|---|---|---|
| Threshold Placement | Earlier or later modeled onset coordinate. | onset time |
| Binding Sensitivity | Modeled amplification or compression. | onset variability comparison |
| Coupling Geometry | Slope-driven modeled shaping. | peak variability comparison |
Modeled smoking-effect onset and effectiveness differences arise from the interaction of parameterized PK trajectories with a defined PD transformation. Absorption rate controls rising-phase steepness, absorption timing controls temporal placement, solubility shapes dissolution-driven input, and gastric emptying determines modeled input arrival. Absorption-window width controls how broadly input is distributed. Distribution loading, distribution geometry, and redistribution timing shape concentration placement and movement between modeled compartments. Clearance geometry, first-pass metabolism, bioavailability, and concentration-dependent clearance modify trajectory scale and curvature. Dose-scaling geometry determines how parameterized inputs are compared. Tmax geometry identifies modeled peak position, while Cmax geometry represents modeled peak amplitude. The PD layer then transforms these differences through threshold placement, binding sensitivity, coupling geometry, and noise bands. “Onset” and “effectiveness” therefore describe mathematical coordinates within the PK→PD model, not real-world timing or outcomes.
The principal PK mechanisms are absorption, distribution, and elimination geometry represented through parameterized model terms. Absorption rate controls the steepness of the rising concentration phase, while absorption timing determines its position on the modeled time axis. Solubility affects the dissolution-driven input function, gastric emptying affects modeled arrival of that input, and absorption-window width determines whether input is concentrated or dispersed. Distribution loading sets early central concentration placement, distribution geometry controls compartmental movement, and redistribution timing shapes later transitions. Clearance geometry determines the removal trajectory, while first-pass metabolism and bioavailability influence the systemic input available to the modeled compartments. Dose-scaling geometry controls how different input levels are represented. Tmax geometry describes modeled peak location, and Cmax geometry describes modeled peak amplitude. Concentration-dependent clearance can modify curvature across concentration ranges. Together, these mechanisms create the PK trajectory subsequently interpreted by the PD layer.
Four primary PD mechanisms shape the interpretation geometry: threshold placement, binding sensitivity, coupling geometry, and PD noise bands. Threshold placement defines the concentration coordinate at which the modeled PD state crosses a selected boundary, thereby determining the mathematical onset coordinate. Binding sensitivity controls how concentration differences are converted into differences in the modeled binding relationship. Higher sensitivity can increase separation between trajectories, while lower sensitivity can compress that separation. Coupling geometry determines how the binding representation is transformed into a downstream PD signal, with slope and curvature controlling the resulting shape. PD noise bands surround calculated coordinates with a modeled interpretation range, representing parameterized variability or uncertainty rather than observed outcomes. These mechanisms operate downstream of the PK trajectory. Consequently, identical PK differences can produce different modeled interpretations when PD parameters change, and similar PD coordinates can arise from different PK trajectories when the transformation compensates for underlying concentration differences.
Modeled smoking-effect trajectories differ because each parameter set defines a different mathematical representation of absorption, distribution, metabolism, elimination, or PD transformation. Changing absorption rate alters rising-phase slope, while changing absorption timing shifts the input coordinate. Solubility and gastric emptying modify the modeled input function, and absorption-window width changes its temporal spread. Distribution loading changes early concentration placement, while distribution geometry and redistribution timing alter compartmental movement. Clearance geometry changes the descending trajectory, and concentration-dependent clearance can introduce concentration-related curvature. First-pass metabolism and bioavailability modify systemic input, while dose-scaling geometry determines how the modeled input is scaled. Tmax and Cmax geometry can therefore differ between parameter sets. Afterward, threshold placement, binding sensitivity, coupling geometry, and PD noise bands transform the PK differences into different interpretation regions. The resulting trajectories are mathematical simulations of parameter interactions, not representations of individual clinical responses, observed outcomes, or real-world smoking interaction timing.
PK→PD mapping explains modeled smoking-effect differences by treating the PK concentration trajectory as the input to a mathematical PD transformation. PK parameters first determine the trajectory's shape, position, and amplitude. Absorption rate and timing define the rising phase, while solubility, gastric emptying, and absorption-window width shape input delivery. Distribution loading, distribution geometry, and redistribution timing determine concentration movement across modeled compartments. Clearance geometry, first-pass metabolism, bioavailability, dose-scaling geometry, Tmax geometry, and Cmax geometry further define the trajectory. The PD layer then applies threshold placement to locate the modeled onset boundary, binding sensitivity to transform concentration differences, and coupling geometry to shape downstream signal coordinates. PD noise bands create interpretation ranges around those coordinates. Thus, modeled onset and effectiveness geometry are emergent properties of sequential PK and PD transformations. The framework describes how parameter changes propagate mathematically and does not imply real-world effectiveness, patient outcomes, or actual smoking-related timing.